Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

Rhea-AI Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will release its financial results for Q4 and the full year 2021 before the market opens on February 24, 2022. The company's management will host a conference call at 5:30 a.m. PT / 8:30 a.m. ET to discuss these results along with updates on business developments and future outlook. Audio of the webcast will be accessible in the 'Investors' section of the Nautilus website.

Nautilus is focused on developing a single-molecule protein analysis platform aimed at advancing proteomics and improving healthcare.

Positive

• Scheduled financial results release indicating transparency and investor communication.
• Development in creating a single-molecule protein analysis platform has potential to transform proteomics.

Negative

• None.

SEATTLE, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the fourth quarter and full year 2021 before market open on Thursday, February 24^th, 2022.

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.

Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio

Contacts

Investors:
InvestorRelations@nautilus.bio

Media:
Thermal for Nautilus Biotechnology
Kaustuva Das
Press@nautilus.bio

FAQ

When will Nautilus Biotechnology report its Q4 2021 financial results?

Nautilus Biotechnology will report its Q4 2021 financial results on February 24, 2022.

What time will the Nautilus conference call take place?

The conference call will begin at 5:30 a.m. PT / 8:30 a.m. ET.

How can I access the Nautilus webcast?

The webcast will be available in the 'Investors' section of the Nautilus website.

What is the focus of Nautilus Biotechnology?

Nautilus is focused on developing a platform for analyzing the proteome to advance human health and medicine.

What is the stock symbol for Nautilus Biotechnology?

The stock symbol for Nautilus Biotechnology is NAUT.